Senseonics Announces Initiation of European Commercial Efforts by Partner Ascensia Diabetes Care
Published: Feb 01, 2021 GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that Ascensia Diabetes Care (Ascensia) has commenced sales and marketing activities for the Eversense® XL CGM system in key European markets as of today, as part of their strategic partnership announced in August, 2020. “Today, we are extremely excited to see Ascensia, a global leader in...
Source: biospace.com
